Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hyperpolarization
100%
C-type Natriuretic Peptide
100%
Induced Endothelial Cells
100%
Ion Channels
18%
L-NAME
18%
Endothelial Nitric Oxide Synthase (eNOS)
18%
Endothelial Cells
18%
Second Messenger
18%
Channel Blocker
18%
Patch Clamp
18%
Soluble Guanylyl Cyclase
18%
Natriuretic Peptide Receptor B
18%
Perforated Patch
18%
Pulmonary Microvascular Endothelial Cells (PMVECs)
18%
Iberiotoxin
18%
Ca2+
9%
Small Interfering RNA (siRNA)
9%
Selective Inhibitor
9%
Knockdown
9%
Vascular Smooth muscle Cells
9%
Potentiometric Dye
9%
Electrophysiological Effects
9%
Membrane Potential
9%
1H-1
9%
Fluorescence Imaging
9%
Imaging Experiment
9%
La3+
9%
Outward Current
9%
SK Channels
9%
Pharmacological Inhibitors
9%
Tetraethylammonium
9%
Tion
9%
Repletion
9%
RNA-based
9%
Nitric Oxide Synthase Inhibitors
9%
Cation Channel
9%
Dose-dependent
9%
8-bromo-cAMP
9%
Target Receptors
9%
Clamping Experiments
9%
Quinoxaline
9%
Medicine and Dentistry
Endothelial Cell
100%
Natriuretic Peptide Type C
100%
Ion Channel
18%
Patch Clamp
18%
Iberiotoxin
18%
Endothelial Nitric Oxide Synthase
18%
Natriuretic Peptide Receptor B
18%
Guanylate Cyclase
18%
Second Messenger
18%
Receptor
9%
Small Interfering RNA
9%
Potassium Channel
9%
Cation Channel
9%
Vascular Smooth Muscle Cell
9%
Membrane Potential
9%
Potassium Ion
9%
Tetrylammonium
9%
Channel Blocker
9%
Arginine Methyl Ester
9%
BK Channel
9%
Guanylate Cyclase Inhibitor
9%
1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One
9%
Nitric Oxide Synthase Inhibitor
9%
Cyclic GMP
9%
Neuroscience
Natriuretic Peptide Type C
100%
Ion Channel
18%
Second Messenger System
18%
Iberiotoxin
18%
Channel Blocker
18%
Patch Clamp
18%
Endothelial Nitric Oxide Synthase
18%
Natriuretic Peptide Receptor B
18%
Guanylate Cyclase
18%
Potassium Channel
9%
Vascular Smooth Muscle
9%
Membrane Potential
9%
Cation Channel
9%
Small Interfering RNA
9%
Agonist
9%
Tetraethylammonium
9%
BK Channel
9%
Arginine Methyl Ester
9%
Receptor
9%
Cyclic Guanosine Monophosphate
9%
Pharmacology, Toxicology and Pharmaceutical Science
Natriuretic Peptide Type C
100%
Ion Channel
18%
Natriuretic Peptide Receptor B
18%
Channel Blocker
18%
Iberiotoxin
18%
Endothelial Nitric Oxide Synthase
18%
Guanylate Cyclase
18%
Potassium Ion
9%
Small Interfering RNA
9%
Receptor
9%
Cation Channel
9%
Potassium Channel
9%
Tetrylammonium
9%
Cyclic GMP
9%
1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One
9%
Nitric Oxide Synthase Inhibitor
9%
Large Conductance Calcium Activated Potassium Channel
9%
Arginine Methyl Ester
9%
Guanylate Cyclase Inhibitor
9%